Article Contents
| Clin Exp Pediatr > Volume 66(1); 2023 |
|
| Study | Pathogens | Study details | Results/conclusions |
|---|---|---|---|
| Leung et al. [20] (1993) | Staphylococcus aureus | Control study | Selective expansion of Vβ2 + T cells in most patients with KD may be caused by a toxic shock syndrome toxinproducing S. aureus, and in a minority of patients, SPEBproducing or SPEC-producing streptococci. |
| Streptococcus pyogenes | 16 Acute KD patients & 15 controls | ||
| Matsubara and Fukaya [22] (2007) | Group A Streptococcus | Review recent publications | Evidences support the involvement of superantigens in the pathogenesis of KD: |
| Staphylococcus aureus | Total number of known staphylococcal superantigens to over 20 and streptococcal superantigens to 12 | - the skewed distribution of the Vβ repertoire; | |
| - superantigen-producing bacteria has been isolated from KD patients; | |||
| - the serological responses to superantigens produced by S. aureus and GAS from case-control studies; and | |||
| - animal models have demonstrated all the hallmarks of a superantigen-mediated response. | |||
| Konishi et al. [24] (1997) | Yersinia pseudotuberculosis | Case report | Y. pseudotuberculosis might be closely related to the cause of KD. |
| 5-year-old boy, KD with CAL | |||
| Mitogenic activity by culture and PCR | |||
| Keren et al. [26] (1983) | Pseudomonas aeruginosa | Case report | Pseudomonas infection appeared to be the underlying cause of both the clinical symptoms and the pathological changes of Kawasaki disease. |
| Clinical, laboratory and histopathological findings of 13 patients with KD | |||
| Normann et al. [27] (1999) | Chlamydiae pneumoniae | Case report | First report about the demonstration of C. pneumoniae in cardiovascular tissues from children with KD |
| 8-year-old boy | |||
| Immunohistochemical study for tissue | |||
| Tang et al. [28] (2016) | Mycoplasma pneumoniae | Prospectively analysis of clinical records | MP infections are found in an important proportion of the KD patients (13.8 % in our series). |
| 450 Patients with KD (2012–2014) |
| Study | Viruses | Study details | Results/conclusions |
|---|---|---|---|
| Okano et al. [30] (1990) | Adenovirus | Retrospective study | Two of 12 (16.7%) in 1982 and 1 of 10 (10.0%) in 1985 showed positive antibodies for the common adenovirus antigen by CF test. By ELISA test, 9 of 12 (75.0%) in 1982 and 9 of 10 (90.0%) in 1985 had antibodies to adenovirus type 2. |
| Herpes simplex virus type 1 & 2 (HSV-1 & HSV-2) | Two outbreaks of KD at different times and areas (12 patients Kyoto in 1982 and 10 Sapporo in 1985), Antibody detection by CF and ELISA | ||
| Varicella-zoster virus (VZV) | No significant difference HSV-1 and HSV-2, VZV, and CMV between patients and controls | ||
| Cytomegalovirus (CMV) | |||
| Rosenfeld et al. [31] (2020) | Epstein-Barr virus (EBV) | Case report | Concomitant EBV infection was supported by positive serology for acute EBV infection (positive IgM VCA EBV antibodies). |
| 19-month-old boy | |||
| KD with a concomitant primary EBV infection | |||
| Holm et al. [33] (1995) | Parvovirus B19 | Case report | Serologically diagnosed parvovirus B19 infection in KD patients supports the hypothesis of an etiological relationship between parvovirus B19 infection and KD. |
| 9-week-old boy | |||
| Okano et al. [34] (1989) | Human herpesvirus 6 | Case-control study | Eighteen of 22 (81.8%) with KD were positive for immunoglobulin G or M antibodies to human herpesvirus 6, whereas 10 of 16 age- and sex-matched healthy controls (62.5%) were seropositive. |
| 22 patients with KD, and 16 age- and sexmatched healthy controls | Human herpesvirus 6 infection may be a reflection of the immunologic alterations that are associated with KD. | ||
| Matsuno et al. [36] (1983) | Rotavirus | Case-control study | A significant increase in antibody to rotavirus was 38 cases (50.7%) in KD, otherwise 3 cases(7.8%) in controls. |
| Serology test for 75 patients with KD and 39 age-matched healthy controls | |||
| Singh et al. [38] (2009) | Dengue virus | Case report | A child presenting with fever and rash, can have more than one underlying condition. |
| 8-year-old boy | |||
| Dengue IgM antibody(+), developed findings consistent with KD | |||
| Lee et al. [39] (2004) | Varicella-zoster virus | Case report | Two sisters showed a characteristic feature of KD immediately after a primary infection by VZV. |
| 4-year-old & 5-year-old (sisters) | VZV infection may cause severe complication and may be associated with KD. | ||
| Belostotsky et al. [40] (2004) | Human immunodeficiency virus (HIV) | Case report | Atypical KD with coronary artery aneurysm formation in an HIV-infected adolescent suggests that KD may occur in patients with immunodeficiency. |
| 14-year-old boy with advanced perinatal HIV infection | |||
| Shirato et al. [41] (2014) | Human corona virus (HCoV)-NL63, HCoV-229E | Case-control study | Serological tests did not support the involvement of HCoVNL63 but suggested the possible involvement of HCoV-229E in the development of KD. |
| 15 Patients with KD and 23 controls & 29 controls, by IF assays and virus neutralizing tests | |||
| Catalano-Pons et al. [42] (2007) | Human bocavirus (HBoV) | Nasopharyngeal, serum or stool samples from 16 patients with KD by PCR | HBoV was identified in 5 patients (31.2%) by PCR, suggesting that this virus may also play a pathogenic role in some cases of KD. |
| Giray et al. [43] (2016) | Adenovirus, HCoV-OC43/HKU1, Parainfluenza virus type 3 | 4 cases report | Adenovirus in 4-year-old boy & 3-year-old boy, HCoV-OC43/HKU1 in 17-month-old girl |
| Parainfluenza virus type 3 in 4-year-old girl | |||
| Song et al. [44] (2016) | Adenovirus | Comparative study | Twenty-four of 25 children with adenovirus disease and mimicking features of KD had <4 KD-like features |
| 31 Patients with KD | |||
| Thissen et al. [45] (2018) | Torque teno virus(TTV) 7 | Case-control study | Sanger sequencing revealed that the TTV 7 found in the 2 KD patients contained almost identical variants in nucleotide and identical changes in resulting amino acid, relative to the reference sequence |
| 11 Patients with KD and 22 controls | |||
| Wang et al. [46] (2019) | Influenza A (H1N1) pdm09 | Case report | More attention should be paid to the correlation between KD and pathogen infection, especially the new influenza virus H1N1. |
| 19-month-old boy | |||
| Choe et al. [47] (2020) | HCoV | Big data analysis(2016–2019) | Cumulative association of KD per 10% increase of HCoV over 1 month‐lag was 0.50 (95% CI, 0.16–1.53), suggesting that seasonal variation in the frequencies of HCoV was not significantly associated with the incidence of KD. |
| Using national representable data from sentinel surveillance and the Health Insurance Review & Assessment Service | |||
| Quiat et al. [51] (2020) | 58 viruses | Detection of antiviral antibodies in KD patients and matched controls. | No differences in antiviral antibody profiles. |
| Comprehensive serological profiling using a high-throughput PhIP-seq. assay | In the acute and subacute phases of disease, there is no serological evidence that KD patients are exposed to known viruses than controls. | ||
| Aguirre et al. [52] (2021) | Respiratory syncytial virus (RSV), Influenza A & B virus, Metapneumovirus | Ecologic study of respiratory viruses in Chile, between 2010–2017. | There is a direct temporal correlation between RSV, influenza A, influenza B, and metapneumovirus circulation and KD. |
| Farahmand et al. [60] (2021) | Human parvovirus B19 | Meta-analysis | Human parvovirus B19, EBV, human herpesvirus-6 are highly suspected to be key contributors to the development of KD. |
| EBV | Search for relevant studies (1984–2019) | ||
| Human herpesvirus-6 | |||
| Lim et al. [17] (2021) | 11 Respiratory viruses | National data from Health Insurance Review and Assessment in Korea by Granger test | Positive detection rate for RSV, rotavirus, rhinovirus and norovirus were related with KD incidence by 1 or 2 months. |
| Kang et al. [18] (2022) | 14 Respiratory viruses | Cohort study for 53,424 with KD | Respiratory infections caused by rhinovirus and RSV and varicella outbreaks were significantly correlated with KD at 1 to 3 months before KD outbreaks. |
| National data from Korean National Health Insurance Service(Dec. 2020–Oct. 2021) |
| Study | Vaccines | Study details | Results/conclusions |
|---|---|---|---|
| Miron et al. [62] (2003) | Hapatitis B | Case report | KD occurred 1 day after receiving second dose of hepatitis B vaccine. |
| 35-day-old infant | When there is a strong temporal relationship between HBV and KD, it should be considered to withhold additional doses of hepatitis B vaccine. | ||
| Yin et al. [63] (2015) | Rotavirus & hepatitis A | Case report | KD after second dose of Lanzhou lamb rotavirus vaccine and first dose of freeze-dried live attenuated hepatitis A vaccine |
| 20-month-old girl | |||
| Shimada et al. [64] (2015) | Influenza | Case report | Although the mechanism underlying the development of influenza vaccine-induced vasculitides is unknown, a possible link between influenza vaccination and autoimmunity has been suggested, and influenza vaccination possibly served as a trigger for the development of KD. |
| 2-year-old girl, received 2 doses of the influenza vaccine 36 and 8 days before the onset of KD | |||
| Bonetto et al. [65] (2016) | Influenza, HBV, BCG, HPV, MGC, HAV, Rotavirus, DPT, Typhoid fever, MMR, Yellow fever, Anthrax, Pandemic influenza | Review | Vasculitis were more frequently reported in association with influenza vaccines. |
| 75 Articles from 1st January 1994 to 30th June 2014 | |||
| Hua et al. [66] (2009) | RotaTeq & 22 types of FDA licensed vaccines | Case analysis | Does not suggest an elevated KD risk for RotaTeq or other vaccines. |
| 107 KD in total of 239,535 reports by vaccine adverse event reporting system for all US licensed vaccines since 1990 to 2007 | |||
| Abrams et al. [67] (2015) | Varicella, Influenza, Pertussis, Mumps, Pneumococcus, Hepatitis A or B, Haemophilus influenzae type b, Measles, Tetanus, Rubella, Diphtheria, Polio | Longitudinal, multi-site study on 1.7 million children for 4.4 million person-years. | Observed decreased rate of KD during 42 days after vaccination. |
| Data from the Vaccine Safety Datalink were collected from 7 managed care organizations across the United States for children aged 0–6 years (1996–2006). | No evidence for increased rate of Kawasaki disease following vaccination. Findings provide strong evidence that vaccines are not a cause of Kawasaki disease. | ||
| Peralta-Amaro et al. [68] (2022) | COVID-19 (nonreplicable viral vector Vaxzevria) | Case report | Symptoms begin 22 days after the application first dose of the COVID-19 vaccine This is the first case described of atypical KD after COVID-19 vaccination. |
| 18-year-old man |
KD, Kawasaki disease; HBV, hepatitis B vaccination; BCG, Bacille Calmette-Guerin; HPV, human papillomavirus vaccination; MGC, meningococcal vaccination; HAV, hepatitis A vaccination; DPT, diphtheria, pertussis, and tetanus vaccination; MMR, measles, mumps, and rubella vaccination; FDA, U.S. Food and Drug Association; RotaTeq, rotavirus live vaccine; COVID-19, coronavirus disease-2019.
COVID-19, coronavirus disease-2019; SARS-CoV-2 Severe acute respiratory syndrome coronavirus-2; ARDS, acute respiratory distress syndrome; MAS, macrophage activation syndrome; CAL, coronary artery lesion; IVIG intravenous immunoglobulin; IL, interleukin.
Modified from Kabeerdoss et al. Rheumatol Int 2021;41;19-32. [79]
| Study | Study details | Results/conclusions |
|---|---|---|
| Jones et al. [69] (2020) | Case report | He also screened positive for COVID-19 in the setting of fever and minimal respiratory symptoms. |
| 6-month-old infant with a classic KD | The patient was treated per treatment guidelines, with IVIG and high-dose aspirin, and subsequently resolution of clinical symptoms without CAL. | |
| Cazzaniga et al. [70] (2020) | Case report | PCR tests showed that this patient was infected by enterovirus, rhinovirus, and SARS-COV-2. It is difficult to understand which of the 3 viral agents had been the trigger. |
| 6-year-old boy with a complete form of KD | ||
| Renganathan et al. [71] (2021) | Case report | SARS-CoV-2 infection triggered the recurrence of KD in children who might have been genetically predisposed to KD. |
| 10-year-old boy, who had previously developed KD at 4 years of age | ||
| Riphagen et al. [72] (2020) | Case report | This clinical picture represents a new phenomenon affecting previously asymptomatic children with SARS-CoV-2 infection manifesting as a hyperinflammatory syndrome with multiorgan involvement similar to Kawasaki disease shock syndrome |
| Unprecedented cluster of 8 children with hyperinflammatory shock, showing features similar to atypical Kawasaki disease, KD shock syndrome | ||
| Gkoutzourelas et al. [73] (2020) | Review | MIS-C related to the SARS-CoV-2 pandemic (also termed Kawasaki-like disease, or Kawa-COVID-19) appears to share clinical, pathogenetic and laboratory features with KD, toxic shock syndrome, and MAS. |
| KD and COVID-19. | ||
| Sancho-Shimizu et al. [74] (2021) | Review | SARS-CoV-2 is the trigger for MIS-C, which typically occurs about 1 month after infection |
| SARS-CoV-2 related MIS-C | Suggest that rare inborn errors of immunity altering the immune response to SARS-CoV-2 may underlie the pathogenesis of MIS-C in some children | |
| Verdoni et al. [3] (2020) | Observational cohort study | Thirty-fold increased incidence of Kawasaki-like disease: 19 patients in group 1, 10 patients in group 2. |
| Kawasaki-like disease incidence: before(group 1, 5 years) or after (group 2, 2 months) SARS-CoV-2 epidemic | SARS-CoV-2 epidemic was associated with high incidence of a severe form of Kawasaki disease | |
| Kang et al. [4] (2021) | Retrospective ecologic study | KD incidence decreased significantly after the implementation of nonpharmacological interventions in Korea |
| Ae et al. [5] (2021) | Epidemiologic study | During the social distancing period in 2020, KD was approximately 35% lower than in 2017-2019. The weekly reduction in patient numbers differed between KD and PIDs during 2020, with no strong correlation between the 2 diseases. However, these findings indicate the possibility that triggering KD might be associated with unidentified respiratory pathogens. |
| Association between KD and common pediatric infectious diseases (PIDs) during COVID-19 | ||
| Yang and Kuo[6] (2021) | Retrospective case series study | Compared with the 2018 and 2019 databases, KD incidence decreased significantly by 30% and 31%, respectively (P<0.05) in 2020, when public health interventions were comprehensively implemented in Taiwan. Is KD a preventable disease? |
| Patients with KD between 2018 and 2020 were included for trend analysis | ||
| Kim et al. [79] (2020) | Case report | The first case in Korea |
| 11-year-old boy with MIS-C related COVID-19 | The child fully recovered after treatment corresponding to KDSS. | |
| Kabeerdoss et al. [79] (2021) | Review | Clinical manifestations of MIS-C mimic KD shock syndrome. MIS-C develops 4-6 weeks following SARS-CoV-2 infection, and is presumably initiated by adaptive immune response. |
| MIS-C caused by SARS-CoV-2 | ||
| Rhim et al. [80] (2022) | Review | Immunopathogenesis is similar among these diseases and suggests that the host's common regulatory system may act for each insult |
| Severe COVID-19, KD, and MIS-C | ||
| Xu et al. [81] (2020) | Comment | SARS-CoV-2 infection and hyperinflammation in COVID-19 could be acting as the "priming trigger" that could lead to KD |
| Potential link between COVID-19 and KD |
SARS-CoV-2, severe acute respiratory syndrome coronavirus-2; KD, Kawasaki disease; COVID-19, coronavirus disease 2019; IVIG intravenous immunoglobulin; CAL, coronary artery lesion; MIS-C, multisystem inflammatory syndrome in children; MAS, macrophage activation syndrome; KDSS, Kawasaki disease shock syndrome.